By the same logic, it could be speculated that an increased level of CD3+CD161+ cells (or an unexplained increase from the baseline) in yet undiagnosed future MS patients, may predict an upcoming clinically isolated syndrome as a first episode of MS. The gene discussed is KLRB1; the disease is myeloid sarcoma.